PHILIPS ENHANCED PET/CT SOLUTIONS BRING ADVANCED IMAGE QUALITY AND CONSISTENCY TO CLINICIANS

At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 Annual Meeting, Vancouver, British Columbia, Canada, June 8-12, Royal Philips (NYSE: PHG, AEX: PHI) is showcasing new updates to its Advanced Molecular Imaging (AMI) portfolio, including the new Ingenuity TF Elite Package: a dose- management solution that offers the latest advances in reconstruction techniques, workflow improvement, and detector technologies to deliver personalized results to clinicians and their patients. The latest Philips solutions offer meaningful innovation to solve clinical challenges by providing clinicians with enhanced image quality, consistency, lesion detectability and low dose.

Philips molecular imaging solutions transform care by personalizing images based on the specific needs of patients. The new package for Ingenuity TF PET/CT systems enhances CT imaging with low dose to the patient, fast acquisition and reconstruction of images. The benefits of the Ingenuity TF Elite Package include:

• NanoPanel Elite Detector: Offers a pure electronic signal, and allows low x-ray techniques without distortion.

• iPatient: Comprehensive set of dose management tools that allows the ability to define exactly what clinicians need in terms of image characteristics, so the settings can be adjusted automatically. This allows clinicians to plan the results, instead of the acquisitions. iPatient is also a means to share protocols among colleagues to allow for consistency across scans. This helps reduce total exam time, and the time the clinician needs to spend preparing and acquiring the scan.

• SyncRight: Allows for easy and efficient communication between the CT system and the injector in order to facilitate delivering appropriate contrast dose and consistent image quality.

The package also includes the award winning iDose⁴ Premium Package, comprised of two leading Philips technologies: iDose⁴ and metal artifact reduction for large orthopedic implants (O-MAR). iDose⁴ improves image quality by reducing artifacts for high image quality at low dose. O-MAR complements this by reducing the artifacts that result from patients’ large orthopedic implants, which typically hinder clear, accurate images from being acquired.

“Philips has a continuing commitment to develop innovative solutions, in partnership with our clinicians, to help improve patient care and provide better access to care,” said Jamie Valliant, vice president and general manager, Advanced Molecular Imaging, Philips Healthcare. “We are driven by our desire to create the future of health care, and the updates we are featuring at SNMMI are a testament to the long-standing legacy Philips has in improving nuclear medicine and advanced molecular imaging solutions.”

Philips will also feature additional solutions that help transform advanced molecular imaging care:

• 3T MultiTransmit for Ingenuity TF PET/MR: The latest advancement in Philips’ MR technology, MultiTransmit provides enhanced signal and image contrast uniformity and consistency across different size patients and up to 40 percent faster MR acquisitions.

• IntelliSpace Portal Molecular Imaging Applications for BrightView SPECT and BrightView XCT SPECT/CT: IntelliSpace Portal, Philips’ scalable multi-modality server-client based processing and review solution, is now available with a full suite of applications for molecular imaging. IntelliSpace Portal offers tools to improve collaboration with referring physicians, provides increased long-term economic value through a scalable multi-modality platform and allows access from virtually anywhere to processing and review applications.